Sutro Biopharma prices $110 million stock offering at $13.98 per share Feb 10, 2026 07:06AM
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering Feb 10, 2026 07:00AM
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: RA CAPITAL MANAGEMENT, L.P. Aug 14, 2025 06:10PM
Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: RA CAPITAL MANAGEMENT, L.P. Apr 4, 2025 04:32PM
Sutro Biopharma Announces Closing of $98.0 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares May 14, 2020 04:01PM


Mar 26, 2020 07:00AM SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia